Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New Study Shows Abnormal Lipid Levels are Highly Common in Statin-Treated Patients
Marketwatch
Monday, August 31, 2009 - 7:59am
tags:
statins
Interview with Access Pharma CEO: Updates and Outlook
Seeking Alpha
Monday, August 31, 2009 - 7:47am
tags:
Access Pharmaceuticals, Pharma CEOs
Sanofi’s Experimental Anti-Clot Drug Shows Promise
Bloomberg
Monday, August 31, 2009 - 7:45am
tags:
Sanofi, anticlotting, Otamixaban
Regulatory questions for Astra, Boehringer drugs
Reuters
Monday, August 31, 2009 - 7:44am
tags:
Boehringer Ingelheim, AstraZeneca, Pradaxa, Brilinta
Wyeth responds to criticism
FT.com
Monday, August 31, 2009 - 7:42am
tags:
Wyeth, HRT, Prempro, Premarin
Study could boost new Astra-Zeneca drug
Marketwatch
Monday, August 31, 2009 - 7:41am
tags:
AstraZeneca, Plavix, Brilinta
BioElectronics Announces Completion of Clinical Study -- Preparing FDA 510(K) Pre-Marketing Notifica
PR-USA.net
Sunday, August 30, 2009 - 9:49am
tags:
MorphoSys
Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Yahoo/PR NewsWire
Sunday, August 30, 2009 - 9:41am
tags:
Sanofi, Otamixaban
Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
PR NewsWire
Sunday, August 30, 2009 - 9:38am
tags:
Clopidogrel, Ticagrelor, AstraZeneca
New Drugs Surprise In Barcelona
Forbes
Sunday, August 30, 2009 - 9:37am
tags:
Brilinta, AstraZeneca
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® in Acute Coronary Syndrome Patients Undergoing Angioplasty
Business Wire
Sunday, August 30, 2009 - 9:33am
tags:
Plavix, Bristol-Myers Squibb, Sanofi
BioSante Pharmaceuticals Comments on Study Showing No Increased Risk of Breast Cancer in Women Using Testosterone for Low Libido
PR-Inside
Saturday, August 29, 2009 - 11:28am
tags:
BioSante
Mylan's subsidiary notified by the WHO Prequalification of Medicines Programme
News-Medical.net
Saturday, August 29, 2009 - 11:25am
tags:
Mylan
Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes
Pharmabiz
Saturday, August 29, 2009 - 11:23am
tags:
Takeda, alogliptin, diabetes
Novelos Therapeutics Secures $9 Million Private Placement
Trading Markets
Saturday, August 29, 2009 - 11:22am
tags:
Novelos Therapeutics, Purdue
FDA approves Watson Pharmaceuticals' ANDA for Levonorgestrel tablets
News-Medical.net
Saturday, August 29, 2009 - 11:06am
tags:
Watson Pharmaceuticals, Levonorgestrel
Mylan begins marketing generic BenzaClin to treat acne
Pharmabiz
Saturday, August 29, 2009 - 11:04am
tags:
BenzaClin, Mylan
Generic versions of biologic medications are coming
MarketWatch
Saturday, August 29, 2009 - 11:01am
tags:
biotech, generics
Drug Stock Drag (video)
CNBC
Saturday, August 29, 2009 - 11:00am
tags:
Daxas Shows Promise
Yahoo/Zacks
Saturday, August 29, 2009 - 10:59am
tags:
Forest Labs, Nycomed, Pfizer, GSK, Daxas

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.